Clinical Trial Update: Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of high-dose Symbicort SMART in Japanese asthma patients; results were posted in 2012 after the study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort SMART (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-08-29